Annalese Williams

Penn State Milton S. Hershey Medical Center

Papers

1

Total Citations

2

H-Index

1

About

Dr. Annalese Williams is a rising leader in gynecologic oncology, with a focused research agenda on optimizing perioperative care for women with gynecologic malignancies. Her most-cited work, "Addition of metronidazole to standard-of-care perioperative prophylaxis at the time of hysterectomy for gynecologic malignancies" (2025), has already garnered 2 citations, signaling early impact in a critical area of surgical infection prevention. Dr. Williams’s major contribution lies in evaluating the efficacy of adding metronidazole to standard antibiotic prophylaxis during hysterectomy, a study that addresses a key gap in reducing postoperative infectious complications in a high-risk patient population. This work has direct implications for refining clinical guidelines and improving patient outcomes. Her research bridges the intersection of surgical oncology, infectious disease, and evidence-based practice, demonstrating a commitment to enhancing the safety and quality of care for women undergoing major cancer surgery. As her career progresses, Dr. Williams is poised to become a pivotal voice in perioperative management, with a growing body of work that promises to influence both clinical protocols and future multicenter trials.

Research Focus

Key Achievements

1
H-Index
1
Papers
2
Total Citations
2
Avg Citations/Paper
🏆 Most Cited Paper
Addition of metronidazole to standard-of-care perioperative prophylaxis at the time of hysterectomy for gynecologic malignancies
2 citations · 2025
📈 Most Prolific Year: 2025 (1 Papers)
🤝 Key Collaborators: 11
🏛 Institutions: Penn State Milton S. Hershey Medical Center

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago